| J9271 | Injection, pembrolizumab, 1 mg | 17,800 | $40 | $765.4K |
| J0897 | Injection, denosumab, 1 mg | 9,780 | $20 | $185.8K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,090 | $100 | $110.2K |
| J1437 | Injection, ferric derisomaltose, 10 mg | 6,200 | $20 | $105.4K |
| 99424 | A physician or other qualified healthcare professional personally performs management and care plan services for a patient with a complex chronic condition, expected to last three months, which… | 1,470 | $70 | $95.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 480 | $110 | $51.1K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 27,750 | $1 | $27.8K |
| 99233 | The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 220 | $100 | $21.9K |
| 99223 | The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the… | 140 | $140 | $20K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 140 | $140 | $19.6K |